| scholarly article | Q13442814 |
| P50 | author | Sheila E. Francis | Q38589785 |
| P2093 | author name string | David Evans | |
| David Crossman | |||
| Janet Chamberlain | |||
| Andrea King | |||
| Rachael Dewberry | |||
| Steven Dower | |||
| P2860 | cites work | Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase | Q24336387 |
| Molecular cloning of the interleukin-1 beta converting enzyme | Q24338607 | ||
| A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes | Q28237565 | ||
| Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock | Q28307404 | ||
| Altered cytokine production in mice lacking P2X(7) receptors | Q28586061 | ||
| Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation | Q28591668 | ||
| Granzyme A is an interleukin 1 beta-converting enzyme | Q36364802 | ||
| Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion | Q36400734 | ||
| Multiple biological activities of human recombinant interleukin 1. | Q36993845 | ||
| Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3 | Q37203389 | ||
| Regulation of differentiated properties and proliferation of arterial smooth muscle cells. | Q37997031 | ||
| Arterial smooth muscle. A multifunctional mesenchymal cell | Q39532312 | ||
| Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor | Q39760201 | ||
| Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. | Q40808648 | ||
| Human interleukin 1 beta is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA. | Q41556042 | ||
| Modulation with cytokines of radiation injury: suggested mechanisms of action | Q41702609 | ||
| Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. | Q45191938 | ||
| Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor | Q48319655 | ||
| Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. | Q54197534 | ||
| Neointimal formation by circulating bone marrow cells | Q57221014 | ||
| Circulating bone marrow cells can contribute to neointimal formation | Q57221091 | ||
| Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model | Q61960693 | ||
| Temporal and spatial distribution of interleukin-1β in balloon injured porcine coronary arteries | Q61960714 | ||
| Deficiency of Interleukin-1 Receptor Antagonist Promotes Neointimal Formation After Injury | Q62735844 | ||
| Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation | Q67504159 | ||
| Processing of precursor interleukin 1 beta and inflammatory disease | Q68453302 | ||
| Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries | Q71613838 | ||
| Synergistic interaction of interleukin-1 beta and growth factors in primary cultures of rat aortic smooth muscle cells | Q71707031 | ||
| Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries | Q71792495 | ||
| Characterization of mice deficient in interleukin-1 beta converting enzyme | Q73029429 | ||
| Direct evidence for cytokine involvement in neointimal hyperplasia | Q73030700 | ||
| Response to local inflammation of IL-1 beta-converting enzyme- deficient mice | Q73064409 | ||
| Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis | Q73178283 | ||
| Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages | Q73535863 | ||
| Phenotypic and functional characterization of mice that lack the type I receptor for IL-1 | Q73748033 | ||
| Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis | Q77859042 | ||
| Reanalysis of P2X7 receptor expression in rodent brain | Q80341211 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 1396-1403 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice | |
| P478 | volume | 168 |
| Q36871106 | A Novel Protective Function of 5-Methoxytryptophan in Vascular Injury |
| Q61883672 | A central role for monocytes in Toll-like receptor-mediated activation of the vasculature |
| Q37467840 | A novel mouse model of in situ stenting. |
| Q91291748 | A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension |
| Q47871866 | Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus. |
| Q45002999 | Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution? |
| Q38008700 | Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. |
| Q37026106 | Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials? |
| Q36141649 | Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome |
| Q30318502 | Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis |
| Q42247876 | Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins. |
| Q89365604 | Dietary Docosahexaenoic Acid Reduces Oscillatory Wall Shear Stress, Atherosclerosis, and Hypertension, Most Likely Mediated via an IL-1-Mediated Mechanism |
| Q39102963 | Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin |
| Q26852572 | Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis |
| Q28583222 | Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1alpha |
| Q38752078 | Estimation of Interleukin-1β Promoter (-31 C/T and -511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients |
| Q33685670 | Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans |
| Q55322256 | HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome. |
| Q38605295 | High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration |
| Q37064752 | How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes |
| Q39403443 | IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus |
| Q89964322 | Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome |
| Q36340848 | Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension |
| Q33730487 | Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge |
| Q37141472 | Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding |
| Q34361972 | Lack of interleukin-1 signaling results in perturbed early vein graft wall adaptations |
| Q36344968 | Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease |
| Q34403101 | Moderate hypoxia potentiates interleukin-1β production in activated human macrophages |
| Q38057947 | Most important chronic complications of arteriovenous fistulas for hemodialysis |
| Q36501270 | NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle |
| Q27312465 | Neutrophil elastase promotes interleukin-1β secretion from human coronary endothelium. |
| Q92652489 | Novel Insights Into the NLRP 3 Inflammasome in Atherosclerosis |
| Q36050702 | P2X receptor characterization and IL-1/IL-1Ra release from human endothelial cells |
| Q35649420 | Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation |
| Q41025441 | Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia |
| Q48088302 | Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosis. |
| Q37233061 | Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. |
| Q27009347 | Targeting interleukin-1 in heart disease |
| Q39701214 | Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. |
| Q41599612 | The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease |
| Q35059517 | The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study |
| Q37421811 | Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease |
| Q30319434 | Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms |
| Q26766577 | lncRNA/MicroRNA interactions in the vasculature |
Search more.